Skip to content
NBDC Human Database

No datasets in the cart.

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000648

Type of data
NGS (WGS, Exome, RNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
234 GB
File formats
  • FASTQ
  • BAM
Research
hum0152
Date published
2022-11-10
Date modified
2022-11-10

Analysis method

WGS

Materials and participants
LLTV (ICD10: C49, C51): 1 case
  • Health status
    Affected
  • Subject count
    1 (Individual)
Disease
LLTV (C49, C51)
Sample description
DNA extracted from tumor tissue and blood
  • Tissue
    Peripheral blood
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WGS
Target
N/A
Reagent kit
Twist Library Preparation EF Kit
Fragmentation
Enzymatic fragmentation
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
150 bp
Reference genome
GRCh38
Mapping
BWA-MEM
Mapping quality
MAPQ < 20 were excluded
Coverage (depth)
81x

WES

Materials and participants
LLTV (ICD10: C49, C51): 1 case
  • Health status
    Affected
  • Subject count
    1 (Individual)
Disease
LLTV (C49, C51)
Sample description
DNA extracted from tumor tissue and blood
  • Tissue
    Peripheral blood
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
WES
Target
N/A
Reagent kit
Twist Comprehensive Exome Panel
Twist Library Preparation EF Kit
Fragmentation
Enzymatic fragmentation
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
150 bp
Reference genome
GRCh38
Mapping
BWA-MEM
Mapping quality
MAPQ < 20 were excluded
Coverage (depth)
431x

RNA-seq

Materials and participants
LLTV (ICD10: C49, C51): 1 case
  • Health status
    Affected
  • Subject count
    1 (Individual)
Disease
LLTV (C49, C51)
Sample description
RNA extracted from tumor tissue
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
NEBNext Ultra Directional RNA Library Prep Kit for Illumina
Fragmentation
Enzymatic fragmentation
Platform
Illumina NovaSeq 6000
Read type
Paired-end
Read length
150 bp